Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve Intimation of Board meeting ....
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed stock exchanges that its Board of Directors will meet on Monday, May 26, 2025. The key item on the agenda is the approval of the audited standalone and consolidated financial results for the fourth quarter and full financial year ended March 31, 2025. The company also confirmed that the trading window for insiders remains closed until May 28, 2025, and will reopen on May 29, 2025, in line with SEBI regulations. The meeting notice was signed by B. Adi Reddy, Company Secretary, on May 16, 2025.
This is a routine regulatory filing ahead of the Q4 and FY25 results announcement. Investors should watch May 26, 2025 for the earnings release, which could move the stock based on the company's financial performance, dividend announcements, or any guidance provided.